Epi-collect: Data Collection During Video EEG Monitoring and at Patient's Home
NCT ID: NCT03038191
Last Updated: 2021-09-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
28 participants
OBSERVATIONAL
2017-03-08
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study EEG and other physiologic signals are collected using wearable sensors, from Epilepsy patients who are at risk of experiencing seizures. The collected signals will be used for developing algorithms that may identify pre-seizure and seizure related periods.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DigitalEPI - A Prospective Pilot Study
NCT05739669
EEG@HOME (Phase 4 of the Project)
NCT02394639
EpiCare@Home Validation Study for Focal Onset Seizures
NCT05738226
Remote Tracking of Epilepsy Patients
NCT01130649
Monitoring Patients With Uncontrolled Epilepsy
NCT00001149
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuroelectrics Enobio 8(R)
Monitoring
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Known diagnosis of Epilepsy
* Expected to experience seizures during the period of the study as determined by the PI.
* Able to meet with the Sponsor representative at home
Exclusion Criteria
* Patient can not follow or comply with instructions
* Patients who are unable to independently provide an informed consent
* Patients with major psychiatric co-morbidities
* Patients with psychogenic non-epileptic seizures
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medial Research Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Firas Fahoum, MD
Director, Epilepsy and EEG Service Neurology Division
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tel Aviv Sourasky Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CA-EPIPRO-TASMC-HOSP-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.